# Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery

> **NCT02550145** · PHASE1 · TERMINATED · sponsor: **Tracey McLaughlin** · enrollment: 10 (actual)

## Conditions studied

- Hypoglycemia

## Interventions

- **DRUG:** Exendin (9-39)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02550145
- **Lead sponsor:** Tracey McLaughlin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550145, "Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02550145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*